Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishing Clinical Utility Evidence to Support Coverage and Reimbursement for Venn Biosciences' DawnTM: A CPV® Randomized Controlled Trial

NCT05603299 is registered in ClinicalTrials.gov with Qure Healthcare, LLC as lead sponsor.

NCT NCT05603299
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05603299 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishing Clinical Utility Evidence to Support Coverage and Reimbursement for Venn Biosciences' DawnTM: A CPV® Randomized Controlled Trial
Lead sponsor
Qure Healthcare, LLC
Phase
Not applicable
Overall status
Withdrawn
Start date
June 21, 2023
Completion date
December 18, 2023
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer